Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004-2009. Is rubella susceptibility increasing?

Vaccine

Volumn 30, Issue 2, 2012, Pages 161-167

  Byrne, Lisa ^a   Brant, Lisa ^a,b   Reynolds, Claire ^a   Ramsay, Mary ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antenatal; IgG antibody; Immunisation; Rubella; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RUBELLA ANTIBODY; RUBELLA VACCINE;

ANTIBODY BLOOD LEVEL; ARTICLE; ASIAN; CAUCASIAN; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; SCREENING; SEROPREVALENCE; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ENGLAND; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; RUBELLA; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84355161417     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.045     Document Type: Article

References (42)

1. World Health Organisation Strategic plan for measles and congenital rubella infection in the European Region of WHO 2003, WHO Regional Office for Europe, Copenhagen, Available at http://www.euro.who.int/document/e81567.pdf (last accessed 01.10.10).
2. Department of Health Immunisation against infectous disease - the Green Book 2010, Chapter 28, p. 343-64, Available at http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_119557.pdf (last accessed 01.10.10).
3. Best J.M. Rubella. Semin Fetal Neonatal Med 2007, 12(3):182-192.
4. Zealley H. Rubella screening and immunization of schoolgirls: a long-term evaluation. Br J Prev Soc Med 1974, 28(1):54-59.
5. Tookey P. Rubella in England, Scotland and Wales. Euro Surveill 2004, 9(4):21-23.
6. Miller C.L., Miller E., Sequeira P.J., Cradock-Watson J.E., Longson M., Wiseberg E.C. Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) 1985, 291(6506):1398-1401.
7. Miller E., Waight P., Gay N., Ramsay M., Vurdien J., Morgan-Capner P., et al. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 1997, 7(2):R26-R32.
8. Tookey P.A., Peckham C.S. Surveillance of congenital rubella in Great Britain, 1971-1996. BMJ 1999, 318(7186):769-770.
9. World Health Organisation Progress towards elimination of measles and prevention of congenital rubella infection in the WHO European Region, 1990-2004. Wkly Epidemiol Rec 2005, 80(8):66-71.
10. Health Protection Agency Rubella notifications (confirmed cases), England and Wales, 1995-2010 by quarter (last accessed 01.10.10). http://www.hpa.org.uk/web/HPAweb%26HPAwebStandard/HPAweb_C/1195733784648.
11. Best J.M., Castillo-Solorzano C., Spika J.S., Icenogle J., Glasser J.W., Gay N.J., et al. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee on Research Related to Measles and Rubella Vaccines and Vaccination, June 2004. J Infect Dis 2005, 192(11):1890-1897.
12. Kakoulidou M., Forsgren M., Lewensohn-Fuchs I., Johansen K. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Vaccine 2010, 28(4):1002-1007.
13. Danovaro-Holliday M.C., Gordon E.R., Woernle C., Higginbotham G.H., Judy R.H., Icenogle J.P., et al. Identifying risk factors for rubella susceptibility in a population at risk in the United States. Am J Public Health 2003, 93(2):289-291.
14. Miller E., Nicoll A., Rousseau S.A., Sequeira P.J., Hambling M.H., Smithells R.W., et al. Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) 1987, 294(6574):737-739.
15. Francis B.H., Thomas A.K., McCarty C.A. The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia. Am J Public Health 2003, 93(8):1274-1276.
16. Lemos C., Ramirez R., Ordobas M., Guibert D.H., Sanz J.C., Garcia L., et al. New features of rubella in Spain: the evidence of an outbreak. Euro Surveill 2004, 9(4):9-11.
17. Tookey P.A., Cortina-Borja M., Peckham C.S. Rubella susceptibility among pregnant women in North London, 1996-1999. J Public Health Med 2002, 24(3):211-216.
18. Lao T.T., Suen S.S., Leung T.Y., Sahota D.S., Lau T.K. Universal rubella vaccination programme and maternal rubella immune status: a tale of two systems. Vaccine 2010, 28(10):2227-2230.
19. Tookey P., Molyneaux P., Helms P. UK case of congenital rubella can be linked to Greek cases. BMJ 2000, 321(7263):766-767.
20. Mehta N.M., Thomas R.M. Antenatal screening for rubella-infection or immunity?. BMJ 2002, 325(7355):90-91.
21. Banerji A., Ford-Jones E.L., Kelly E., Robinson J.L. Congenital rubella syndrome despite maternal antibodies. CMAJ 2005, 172(13):1678-1679.
22. Miller E., Waight P., Rousseau S.A., Hambling M.H., Rushton P., Ellis D., et al. Congenital rubella in the Asian community in Britain. BMJ 1990, 301(6765):1391.
23. Sheridan E., Aitken C., Jeffries D., Hird M., Thayalasekaran P. Congenital rubella syndrome: a risk in immigrant populations. Lancet 2002, 359(9307):674-675.
24. UK National Screening Commitee Infectious diseases in pregnancy screening programme. handbook for laboratories 2003.
25. Skendzel L.P. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996, 106(2):170-174.
26. Wysokinska T., Janaszek W., Bucholc B., Gorska P., Gniadek G., Slusarczyk J., et al. The prevalence of anti-rubella antibodies in women of childbearing age in Poland. Vaccine 2004, 22(15-16):1899-1902.
27. Davidkin I., Peltola H., Leinikki P., Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 2000, 18(27):3106-3112.
28. Robinson J.L., Lee B.E., Preiksaitis J.K., Plitt S., Tipples G.A. Prevention of congenital rubella syndrome--what makes sense in 2006?. Epidemiol Rev 2006, 28:81-87.
29. O'Shea S., Best J.M., Banatvala J.E., Marshall W.C., Dudgeon J.A. Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) 1982, 285(6337):253-255.
30. Kremer J.R., Schneider F., Muller C.P. Waning antibodies in measles and rubella vaccines- a longitudinal study. Vaccine 2006, 24(14):2594-2601.
31. Christenson B., Bottiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 1994, 12(1):41-45.
32. Asahi T., Ueda K., Hidaka Y., Miyazaki C., Tanaka Y., Nishima S. Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination. Vaccine 1997, 15(16):1791-1795.
33. Vyse A.J., Gay N.J., Hesketh L.M., Pebody R., Morgan-Capner P., Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 2006, 134(6):1303-1312.
34. Burgess C, Perry K. Evaluation of three rubella IgG enzyme immunoassays. Microbiological Diagnostics Assessment Service (HPA_MiDAS). (last accessed 01.10.10). http://hpa-midas.org.uk/reports/reports_rubella.asp.
35. Health Protection Agency, COVER programme. Completed primary courses at two years of age: England and Wales, 1996-1977, England only 1978 onwards. (last accessed 15.04.11). http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/VaccineCoverageAndCOVER/EpidemiologicalData/coverVaccineUptakeData/.
36. Levy-Bruhl D., Six C., Parent I. Rubella control in France. Euro Surveill 2004, 9(4):15-16.
37. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17(July (7)):1055-1065.
38. Davidkin I., Peltola H., Leinikki P. Epidemiology of rubella in Finland. Euro Surveill 2004, 9(April (4)).
39. Centers for Disease Control and Prevention Elimination of rubella and congenital rubella syndrome - United States, 1969-2004. MMWR Morb Mortal Wkly Rep 2005, 54(11):279-283.
40. Pandolfi E., Chiaradia G., Moncada M., Rava L., Tozzi A.E. Prevention of congenital rubella and congenital varicella in Europe. Euro Surveill 2009, 14(9):16-20.
41. World Health Organisation Accelerated control of rubella and prevention of congenital rubella syndrome, WHO Region of the Americas. Wkly Epidemiol Rec 2003, 78(8):50-54.
42. World Health Organisation Preventing congenital rubella syndrome. Wkly Epidemiol Rec 2000, 36(75):289-296.